An observational study in Anovulation and PCOS, sponsored by Jagiellonian University. Completed at 1 site in Poland. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-04-02.
Sponsored by Jagiellonian University · Observational
The optimal cut-off value for diagnosing hirsutism in the modified Ferriman-Gallwey (mFG) point scale in the Polish population is not known. The correlation of mFG with the severity of androgenetic alopecia in the Ludwig scale (LS) is not known.
The aim of the study is to determine the cut-off point for the diagnosis of hirsutism and to assess the correlation of the mFG scale score with the LS of androgenetic alopecia severity.
The aim of the study is to:
Inclusion criteria are as follows: i) oligoovulation, i.e. menstrual cycles every \<21 days or >35 days, ii) age 18-45 years Exclusion criteria: none
To achieve the study objectives, the following will be performed:
75 studies on the registry are indexed under Anovulation; 7 are open to participants now.
This study's enrollment of 1,330 is above the median of 300 across 17 observational studies indexed under Anovulation.
Browse Anovulation studies →Jagiellonian University is the lead sponsor of 161 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women diagnosed and treated at the University Hospital in Krakow due to normogonadotropic anovulation
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women diagnosed with polycystic ovary syndrome based on International Evidence-based Guideline for the assessment and management of polycystic ovary syndrome (2023)
Diagnostic Test: Assessment of the severity of hirsutism using the visual modified Ferriman-Gallwey scale · Diagnostic Test: Assessment of the severity of endogenetic alopecia using the visual Ludwig Scale
Women diagnosed with hypothalamic-pituitary-ovarian dysfunction based on The FIGO ovulatory disorders classification system (2022)
Diagnostic Test: Assessment of the severity of hirsutism using the visual modified Ferriman-Gallwey scale · Diagnostic Test: Assessment of the severity of endogenetic alopecia using the visual Ludwig Scale
Assessment of the severity of hirsutism using the visual modified Ferriman-Gallwey scale in 9 body regions rated from 0 (no growth of terminal hair) to 4 (extensive hair growth), thus with a score ranging from 0 (the lowest score - no hirsutism) to 36 points (the highest score - the greatest severity of hirsutism)
Visual assessment of baldness on the Ludwig scale from I (least severe baldness) to III (most severe baldness): Type I - minimal thinning of the mid-line parting in the hair; Type II - gradual thinning and noticeable widening of the mid-line parting in the hair; Type III - Heavy to total thinning of the mid-line
Comparison of the severity of hirsutism in the PCOS and HPOD groups
Comparison of the mFG score in the PCOS and HPOD groups; The modified Ferriman-Gallwey (mFG) scale assesses the severity of excessive hair growth on a scale of 0-4 points in 9 body regions (Upper lip, Chin, Chest, Upper back, Lower back, Upper abdomen, Lower abdomen, Upper arms, Thighs); the lowest possible score is 0 and the highest is 36; the higher the score, the greater the severity of excess hair
Time frame: up to 6 months
Comparison of the severity of endogenetic alopecia in the PCOS and HPOD groups
Comparison of the LS score in the PCOS and HPOD groups; The Ludwig Scale (LS) assesses the severity of androgenetic alopecia on a scale from I to III, with additional sub-points within some of the above grades, i.e. I-1, I-2, I-3, I-4, II-1, II-2, III, IV (frontal - advanced); the higher the grade, the greater the severity of alopecia
Time frame: up to 6 months
Calculation of cut-off point for diagnosing hirsutism in the study population
The cut-off point for diagnosing hirsutism will be calculated using the receiver operating characteristic curve
Time frame: up to 6 months
Assessment of diagnostic convergence of mFG and LS scales in diagnosing clinical hyperandrogenism
The correlation of mFG and LS scale scores in the study population will be assessed using standard statistical methods
Time frame: up to 6 months
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.